Maximus (NYSE:MMS) Issues Earnings Results

Maximus (NYSE:MMS) announced its earnings results on Thursday. The health services provider reported $1.61 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.22, Zacks reports. Maximus had a return on equity of 20.95% and a net margin of 5.78%. Maximus updated its FY 2025 guidance to 5.900-6.200 EPS.

Maximus Price Performance

Shares of NYSE:MMS traded down $5.54 on Thursday, reaching $70.29. 1,699,538 shares of the company were exchanged, compared to its average volume of 679,876. The company has a 50-day moving average of $74.87 and a 200-day moving average of $83.62. The company has a current ratio of 1.49, a quick ratio of 1.49 and a debt-to-equity ratio of 0.59. The firm has a market cap of $4.01 billion, a price-to-earnings ratio of 14.06 and a beta of 0.72. Maximus has a 1-year low of $69.72 and a 1-year high of $93.97.

Maximus Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 28th. Shareholders of record on Saturday, February 15th will be issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 1.71%. The ex-dividend date is Friday, February 14th. Maximus’s dividend payout ratio (DPR) is currently 24.00%.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the stock. StockNews.com upgraded shares of Maximus from a “hold” rating to a “buy” rating in a research note on Wednesday, January 29th. Raymond James upgraded shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price objective for the company in a research report on Thursday, January 2nd.

Insider Buying and Selling

In related news, CEO Bruce Caswell acquired 3,500 shares of the business’s stock in a transaction that occurred on Tuesday, December 17th. The stock was purchased at an average cost of $70.64 per share, for a total transaction of $247,240.00. Following the transaction, the chief executive officer now directly owns 275,929 shares of the company’s stock, valued at approximately $19,491,624.56. This trade represents a 1.28 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Michelle F. Link sold 2,208 shares of the firm’s stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $73.83, for a total transaction of $163,016.64. Following the sale, the insider now owns 6,567 shares in the company, valued at approximately $484,841.61. This trade represents a 25.16 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have purchased 7,063 shares of company stock valued at $502,017. Corporate insiders own 1.60% of the company’s stock.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.